884 related articles for article (PubMed ID: 14765316)
1. Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy?
Arguedas MR; Linder JD; Wilcox CM
Endoscopy; 2004 Feb; 36(2):174-8. PubMed ID: 14765316
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin injection after biliary sphincterotomy.
Gorelick A; Barnett J; Chey W; Anderson M; Elta G
Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315
[TBL] [Abstract][Full Text] [Related]
3. Sphincter of Oddi dysfunction: cut and inject, but don't measure the pressure?
Wehrmann T
Endoscopy; 2004 Feb; 36(2):179-82. PubMed ID: 14765317
[No Abstract] [Full Text] [Related]
4. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
[TBL] [Abstract][Full Text] [Related]
5. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB
Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739
[TBL] [Abstract][Full Text] [Related]
6. Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction.
Cheon YK; Cho YD; Moon JH; Im HH; Jung Y; Lee JS; Lee MS; Shim CS
Gastrointest Endosc; 2009 May; 69(6):1111-6. PubMed ID: 19243765
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and therapeutic possibilities in suspected Oddi's sphincter dysfunction].
Wehrmann T; Lembcke B; Jung M
Z Gastroenterol; 1994 Dec; 32(12):694-701. PubMed ID: 7871862
[TBL] [Abstract][Full Text] [Related]
8. Frequency of sphincter of Oddi dysfunction in patients with previously normal sphincter of Oddi manometry studies.
Khashab MA; Watkins JL; McHenry L; Lazzell-Pannell L; Schmidt S; Sherman S; Lehman GA; Fogel EL
Endoscopy; 2010 May; 42(5):369-74. PubMed ID: 19967632
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction.
Geenen JE; Hogan WJ; Dodds WJ; Toouli J; Venu RP
N Engl J Med; 1989 Jan; 320(2):82-7. PubMed ID: 2643038
[TBL] [Abstract][Full Text] [Related]
10. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM).
Maldonado ME; Brady PG; Mamel JJ; Robinson B
Am J Gastroenterol; 1999 Feb; 94(2):387-90. PubMed ID: 10022634
[TBL] [Abstract][Full Text] [Related]
11. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction.
Freeman ML; Gill M; Overby C; Cen YY
J Clin Gastroenterol; 2007 Jan; 41(1):94-102. PubMed ID: 17198071
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction.
Wehrmann T; Seifert H; Seipp M; Lembcke B; Caspary WF
Endoscopy; 1998 Oct; 30(8):702-7. PubMed ID: 9865560
[TBL] [Abstract][Full Text] [Related]
13. The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction.
Lin OS; Soetikno RM; Young HS
Am J Gastroenterol; 1998 Oct; 93(10):1833-6. PubMed ID: 9772040
[TBL] [Abstract][Full Text] [Related]
14. Incomplete response to endoscopic sphincterotomy in patients with sphincter of Oddi dysfunction: evidence for a chronic pain disorder.
Linder JD; Klapow JC; Linder SD; Wilcox CM
Am J Gastroenterol; 2003 Aug; 98(8):1738-43. PubMed ID: 12907327
[TBL] [Abstract][Full Text] [Related]
15. [Endoscopic manometry in suspected dysfunction of the sphincter of Oddi].
Wehrmann T; Jung M; Caspary WF
Dtsch Med Wochenschr; 1996 Apr; 121(16):509-16. PubMed ID: 8612461
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.
Pereira SP; Gillams A; Sgouros SN; Webster GJ; Hatfield AR
Gut; 2007 Jun; 56(6):809-13. PubMed ID: 17005767
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of endoscopic dual pancreatobiliary sphincterotomy in patients with manometry-documented sphincter of Oddi dysfunction and normal pancreatogram.
Park SH; Watkins JL; Fogel EL; Sherman S; Lazzell L; Bucksot L; Lehman GA
Gastrointest Endosc; 2003 Apr; 57(4):483-91. PubMed ID: 12665757
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors in endoscopic manometry for suspected dysfunction of Oddi's sphincter].
Wehrmann T; Wendler OG; Jung M; Caspary WF
Dtsch Med Wochenschr; 1997 Jun; 122(25-26):808-14. PubMed ID: 9244668
[TBL] [Abstract][Full Text] [Related]
19. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction.
Sherman S; Troiano FP; Hawes RH; O'Connor KW; Lehman GA
Am J Gastroenterol; 1991 May; 86(5):586-90. PubMed ID: 2028949
[TBL] [Abstract][Full Text] [Related]
20. Intrasphincteric botulinum toxin type A for the diagnosis of sphincter of Oddi dysfunction: a case report.
Banerjee B; Miedema B; Saifuddin T; Marshall JB
Surg Laparosc Endosc Percutan Tech; 1999 Jun; 9(3):194-6. PubMed ID: 10803999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
